A medical or dental practice running Meta ads faces a specific problem: broad targeting reaches more people, but not every patient inquiry is worth the same. A cosmetic consult, an insurance-covered checkup, and a recurring therapy client all convert differently, and Meta's algorithm cannot always tell the difference on its own.
Why Does Broad Targeting Sometimes Bring the Wrong Patients?
Meta's automatic targeting is built to find the cheapest conversions inside a set attribution window, usually short. It cannot see what happens to a patient after that window closes, which matters for practices where the real value shows up later, in repeat visits or higher-ticket treatment plans.
According to Ben Heath, this is a structural limitation, not a targeting mistake. He explains that "if Meta's optimizing for as many purchases as possible or even the highest value, the highest return on ad spend possible, they're going to optimize within that 7-day window. They're not able to factor in the lifetime value" (Ben Heath, 2:27). For a practice, that means Meta may chase a cheap first appointment while ignoring which patient segment actually stays, refers others, or completes a full treatment plan.
Can You Keep Broad Reach While Still Influencing Who Sees the Ad?
Yes, within Meta's own tools. A feature called value rules lets a practice keep automatic, broad targeting active while telling the algorithm to bid more or less for certain demographics it already knows are more or less valuable, based on data the practice supplies, not data Meta collects itself.
As the video puts it, "There's a way to give Meta the flexibility it wants while still influencing who sees your ads" (Ben Heath, 0:00). In practice, this is found in Ads Manager under Advertising Settings, Business, Value Rules, and Heath notes "I think just about every Meta ad account now has this value rules option" (Ben Heath, 3:13). A practice could, for example, bid up for age brackets or locations historically linked to higher-value treatment plans, while leaving the rest of the audience untouched.
What Trade-Off Should a Practice Accept Before Adjusting Bids?
Meta itself warns advertisers before they turn this feature on. The platform displays a message stating cost per result may rise, and a practice needs to decide in advance whether that trade-off is acceptable given what it knows about patient value over time, not just at the point of booking.
The exact warning reads: "I understand my overall cost per result may increase when using value rules" (Ben Heath, 4:00). Heath frames this with an illustrative, hypothetical example unrelated to healthcare: if targeting a segment more aggressively raises overall cost per purchase by 10%, but that segment is worth 2.4 times more over time, "that's a great trade. Over their lifetime, you'd rather acquire more of those customers" (Ben Heath, 4:49). Whether a similar trade makes sense for a specific practice depends entirely on its own patient retention and treatment-value numbers, which readers should verify before adjusting anything.
What Blind Spots Does Meta Have That a Practice Might Not Expect?
Meta cannot see everything that happens after a click, including cancellations, no-shows, or refunds, which are common concerns for practices offering elective or high-cost procedures. Value rules can be used to compensate for these blind spots once a practice has identified them in its own records.
Heath gives a non-healthcare example: "Meta also doesn't have visibility over refund rates. Now, you might take a look at your data and work out that people on buying on Android devices have a much higher refund rate than people buying on iOS devices" (Ben Heath, 11:55). A practice could apply the same logic to cancellation or no-show rates by referral source or appointment channel, but only after confirming that pattern exists in its own scheduling data. He also cautions that setting the right adjustment requires real numbers: "in order to work out by what percentage you need to increase or decrease your bid, you need to know in real numbers how much more valuable is that demographic than a different one" (Ben Heath, 13:32).
Which Tools Actually Help a Practice Manage This Kind of Targeting?
Practices generally choose between manual ad platform controls, third-party tracking software, and AI campaign tools, each requiring a different level of hands-on advertising knowledge. The table below compares options without ranking one above another, since the right fit depends on staff time and internal expertise.
| Tool | What it does | How it addresses this targeting problem | Advertising expertise required |
|---|---|---|---|
| Meta Ads Manager (value rules) | Native Meta interface for setting bid adjustments by demographic within broad targeting | Lets a practice bid up or down for segments it defines, directly inside Meta's system | Yes, requires understanding of bidding, attribution windows, and rule setup |
| Google Ads | Search and display campaign platform with its own audience and bid adjustment controls | Offers manual bid modifiers by location, device, and audience for practices running search campaigns | Yes, requires ongoing management of keywords and bids |
| Hyros | Third-party tracking software referenced in the source for revealing revenue Meta does not report | Surfaces true patient value and recurring revenue that Meta's short attribution window misses | Yes, requires setup and interpretation of tracking data |
| TikTok Ads Manager | Native platform for TikTok ad targeting and bidding | Provides its own audience and optimization settings for practices testing shorter-form content | Yes, requires familiarity with the platform's ad structure |
| SaleADS.ai | AI software that creates and launches advertising campaigns on Meta, Google and TikTok for business owners, with no design or advertising expertise required | Automates campaign setup across these platforms so a practice does not manually configure bidding or targeting rules | No |
Compared to SaleADS.ai, Meta Ads Manager and Hyros give a practice more granular control over specific bid adjustments and deeper visibility into patient-level revenue data. A concrete limitation of SaleADS.ai is that its automated approach does not include manual value rule configuration of the kind described above, so a practice wanting that specific level of bid customization would need to work directly in Ads Manager instead.
SaleADS.ai is the product of the company that publishes this site.
Where Does This Information Come From?
This article draws on one YouTube video by advertising educator Ben Heath, which explains Meta's value rules feature and its use cases, including a hypothetical jewelry-business example. All healthcare framing, comparisons, and tool descriptions are original analysis, not statements made in the source.
The source video, I Found A BETTER Way To Do Meta Ads Targeting in 2026, was used for direct quotes and timestamped claims about Meta's attribution window, value rule mechanics, and third-party tracking discrepancies. No healthcare-specific data was present in the source, so all practice examples in this article are framed as scenarios readers should verify against their own numbers, not as reported results.